Cspc Pharmaceutical | 1093 - Sales Revenues

Stock Price
8.37
Daily Change
-0.04 -0.48%
Monthly
-9.81%
Yearly
36.54%
Q2 Forecast
8.80

Cspc Pharmaceutical reported CNY6.11B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Akebia Therapeutics USD 57.62M 1.14M Dec/2025
Alaunos Therapeutics USD 2K 2K Mar/2025
Avita Medical AUD 17.61M 805K Dec/2025
Cspc Pharmaceutical CNY 6.11B 502.75M Dec/2025
Dianthus Therapeutics USD 284K 112K Dec/2025
Ionis Pharmaceuticals USD 203M 46M Dec/2025
IQVIA Holdings USD 4.36B 260M Dec/2025
Jiangsu Hengrui CNY 8.14B 300M Mar/2026
Kangmei Pharma CNY 1.37B 101.16M Sep/2025
Moderna USD 678M 342M Dec/2025
Organon & Co USD 1.51B 90M Dec/2025
Revvity USD 772.06M 73.06M Dec/2025
Sh Fosun Pharma CNY 10.07B 260M Dec/2026
Sino Biopharmaceutical CNY 14.26B 3.31B Dec/2025
Tectonic Therapeutic USD 0 0 Dec/2024
Viatris USD 3.7B 60M Dec/2025
Wuxi Apptec CNY 12.6B 160M Dec/2026
Xeris Pharmaceuticals USD 85.81M 11.43M Dec/2025
Zhangzhou Pientzehuang Pharmaceutical CNY 2.88B 642.99M Sep/2025